-
January 31, 2020
R&D Pipeline as of January 2020 -
January 31, 2020
The Third Quarter of FY2019 (April 2019- December 2019) -
November 6, 2019
The Second Quarter of FY2019 (April 2019 - September 2019) -
September 26, 2019
Annual Report 2019 -
July 30, 2019
The First Quarter of FY2019 (April 2019 - June 2019)
-
March 27, 2020
Licensing Agreement for CG0070, a Drug for Bladder Cancer -
February 25, 2020
Transfer of Distribution Operation of MINIRIN MELT® and DESMOPRESSIN Formulations -
February 3, 2020
Transfer of Distribution Operation of MARIZEV® Type-2 Diabetes Treatment -
January 22, 2020
Kissei Announces the Publication of the Results of Phase III Clinical Trials of Rovatirelin for the Treatment of Spinocerebellar Degeneration in the Journal of Neurology, Neurosurgery, and Psychiatry -
December 9, 2019
Positive Results from Uterine Fibroids Phase-III PRIMROSE 2 Trial of Linzagolix
